Tom Cruise's latest film, 'Mission: Impossible – Mortal Sentence Part 1', is encountering unexpected hurdles at the box office, and the phenomenon dubbed 'Barbenheimer' appears to be a significant factor.
Initially, Cruise expressed concerns about 'Oppenheimer' affecting IMAX theaters for his film, but it seems the broader 'Barbenheimer' trend is proving to be a more substantial challenge.
Both 'Oppenheimer' and 'Barbie' have had a considerable impact on the performance of 'Mission: Impossible – Mortal Sentence Part 1'.
The production of 'Mission: Impossible – Mortal Sentence Part 1' incurred a substantial cost of $300 million, given pandemic-related delays and the film's ambitious nature.
Despite an impressive start with nearly $60 million in the United States and a global total of $235 million in its opening three days, the film faced stiff competition.
In its second weekend, with the intensified rivalry from 'Oppenheimer' and 'Barbie', Tom Cruise's film experienced a significant decline, managing only an additional $20 million at the domestic box office. This marked a 65% drop compared to its opening weekend.
As of now, 'Mission: Impossible – Mortal Sentence Part 1' has garnered a total of $370 million worldwide.
However, it still has a long way to go to recoup its budget, not to mention advertising expenses. The film's performance is notably impacted by the soaring demand for 'Barbenheimer', especially 'Barbie', which might further challenge its recovery in terms of theaters and screenings.
